ztalmy
marinus pharmaceuticals emerald limited - ganaxolone - epileptic syndromes; spasms, infantile - andre antiepileptika - ztalmy is indicated for the adjunctive treatment of epileptic seizures associated with cyclin-dependent kinase-like 5 (cdkl5) deficiency disorder (cdd) in patients 2 to 17 years of age. ztalmy may be continued in patients 18 years of age and older.
tilmovet 100 mg/g granulat
huvepharma nv - tilmicosinphosphat - granulat - 100 mg/g - svin
tilmovet 100 g/kg premix
huvepharma nv - tilmicosinphosphat - premix - 100 g/kg - svin
tilmovet 200 g/kg premix
huvepharma nv - tilmicosinphosphat - premix - 200 g/kg - svin
tilmovet 40 g/kg premix
huvepharma nv - tilmicosinphosphat - premix - 40 g/kg - svin
accurate delta vanddispergerbart granulat
fmc agricultural solutions a/s (tidligere: cheminova a/s) - diflufenican, metsulfuron-methyl, metsulfuron - vanddispergerbart granulat - 600 g/kg diflufenican ; 60 g/kg metsulfuron-methyl ; (~ 57,8 g/kg metsulfuron
provera 100 mg tabletter
pfizer aps - medroxyprogesteronacetat - tabletter - 100 mg
valcyte 50 mg/ml pulver til oral opløsning
cheplapharm arzneimittel gmbh - valganciclovirhydrochlorid - pulver til oral opløsning - 50 mg/ml
zyvoxid 20 mg/ml granulat til oral suspension
pfizer aps - linezolid - granulat til oral suspension - 20 mg/ml
amglidia
ammtek - glibenclamid - diabetes mellitus - narkotika anvendt i diabetes - amglidia er indiceret til behandling af neonatal diabetes mellitus, til brug i nyfødte, spædbørn og børn. sulphonylureas som amglidia har vist sig at være effektiv hos patienter med mutationer i gener, der koder for β-celle atp-følsomme kalium kanal og kromosom 6q24-relaterede forbigående neonatal diabetes mellitus.